Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026

Article Date
February 26, 2026

This article is featured on another website.

Go to article

Related posts

Browse all articles
January 28, 2026

Drug Discovery World – JPM 2026: Less talk and more action

January 28, 2026

Drug Discovery World – JPM 2026: Less talk and more action

March 10, 2026

Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors

March 10, 2026

Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors